Recognitions
- Chambers USA has recognized Andrew every year since 2007 and notes Andrew "is a sought-after practitioner." "He has true depth of knowledge and understanding of life sciences, is incredibly responsive and provides great detail and thoughtful analysis to our challenges," report clients. In addition, "he understands business issues and knows when and when not to push the legal issues." "He has seen it all and will guide us through… [h]is experience and judgement are the things I value most."
- He has also been recognized in The Legal 500 United States and The Best Lawyers in America and as a New Jersey Super Lawyer in every year since 2008. In 2003, NJBIZ named him to its Top 40 under 40 list.
- The M&A Atlas Awards, Pharma & Devices Deal of the Year, Winner 2016: Tribute Pharmaceuticals Canada merger with POZEN (Aralez Pharmaceuticals)
- The M&A Atlas Awards, Outstanding M&A Law Firm of the Year Finalist 2016: DLA Piper
- Winner of the New Jersey Technology Council's 2016 Legend of Technology Award
- Financial Services Deal of the Year Award 2015 (over US $100 million) from M&A Advisor in the representation of LLR Partners in the acquisition of CompoSecure, LLC, a leading designer and manufacturer of proprietary financial cards
For more information, pursuant to New Jersey Lawyer Advertising guidance, please click here.
Prior Experience
Prior to joining DLA Piper, Andrew was a partner at an international law firm. Before attending law school, he served as an intern with the NASDAQ trading and corporate bond departments at Shearson Lehman Brothers Inc. and worked as an underwriter for American International Group (AIG). At AIG, Andrew underwrote professional liability and directors' and officers' legal liability insurance policies for several financial services companies.